The Impact of PM+For Moms Intervention on Improving Mother's Mental Health in Zambia (PM+FM)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Depressive Symptoms
- Sponsor
- Swiss Tropical & Public Health Institute
- Enrollment
- 270
- Locations
- 1
- Primary Endpoint
- Change in Mental health symptoms. SRQ-20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
CMHD are particularly prevalent among women, posing a major threat to their own and their children's wellbeing.
Despite the high prevalence of CMHD and the existence of effective treatments, interventions supporting women living in low-resourced settings remain limited.
This study builds on a parent study (Zamcharts NCT03991182), which identified a high prevalence of women with anxiety and/or depression. We propose to design, test, and validate a community-based intervention nested within the public primary health system in Zambia, to identify and treat women with mild-to-severe CMHDs.
Investigators
Irene Falgas Bague
Post-Doctoral Research Collaborator
Swiss Tropical & Public Health Institute
Eligibility Criteria
Inclusion Criteria
- •Women participating in ZamCharts parent study
- •SRQ-20 \>7 (clinically significant symptoms of depression or/anxiety),
- •not planning to move within the next 6 months,
- •with capacity to consent
- •not receiving current mental health care.
Exclusion Criteria
- •Women with active suicidal ideation (determined by Paykel=4 OR 5),
- •severe substance use (ACOK-SUD \>4),
- •mania or psychotic symptoms
Outcomes
Primary Outcomes
Change in Mental health symptoms. SRQ-20
Time Frame: Change between Baseline (at enrollment) and 6 months after enrollment
20 items measuring risk of common mental health problem.
Feasibility of the study
Time Frame: Assessed 4 months after enrollment
% of 1 or more sessions completed. Qualitative feedback from participants and providers.
Acceptability
Time Frame: Assessed 4 months after enrollment
% of participants completing more than 6 sessions. Qualitative feedback from participants and providers.
Secondary Outcomes
- Functionality(Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment)
- Change in Anxiety and Depression symptoms.(Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment)
- World Bank's Toolkit and Inventory(Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment)
- Change in Mental health symptoms. PSYCHLOPS(Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment)